Your browser doesn't support javascript.
loading
Activation of RyR2 by class I kinase inhibitors.
Chakraborty, A D; Gonano, L A; Munro, M L; Smith, L J; Thekkedam, C; Staudacher, V; Gamble, A B; Macquaide, N; Dulhunty, A F; Jones, P P.
Afiliación
  • Chakraborty AD; Department of Physiology, School of Biomedical Sciences, and HeartOtago, University of Otago, Dunedin, New Zealand.
  • Gonano LA; Department of Physiology, School of Biomedical Sciences, and HeartOtago, University of Otago, Dunedin, New Zealand.
  • Munro ML; Centro de Investigaciones Cardiovasculares, CONICET La Plata, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.
  • Smith LJ; Department of Physiology, School of Biomedical Sciences, and HeartOtago, University of Otago, Dunedin, New Zealand.
  • Thekkedam C; Department of Physiology, School of Biomedical Sciences, and HeartOtago, University of Otago, Dunedin, New Zealand.
  • Staudacher V; Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Gamble AB; School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • Macquaide N; School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • Dulhunty AF; Institute of Cardiovascular and Medical Sciences and School of Life Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK.
  • Jones PP; Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Br J Pharmacol ; 176(6): 773-786, 2019 03.
Article en En | MEDLINE | ID: mdl-30588601

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Pirimidinas / Canal Liberador de Calcio Receptor de Rianodina / Inhibidores de Proteínas Quinasas / Sunitinib / Imidazoles / Naftiridinas Límite: Animals / Humans / Male Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Pirimidinas / Canal Liberador de Calcio Receptor de Rianodina / Inhibidores de Proteínas Quinasas / Sunitinib / Imidazoles / Naftiridinas Límite: Animals / Humans / Male Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Nueva Zelanda